Charles River Completes Acquisition of HemaCare
Acquisition establishes a comprehensive cell therapy solution from discovery through commercialization.
Now Available: GMPrime Bone Marrow Aspirate
HemaCare Solutions
At HemaCare, Quality Comes First
HemaCare maintains the highest regulatory compliance in the industry. Setting the Standard
News and Events
-
Charles River Laboratories Completes the Acquisition of HemaCare CorporationThis acquisition expands Charles River’s scientific capabilities in the emerging, high-growth cell therapy sector, creating a comprehensive portfolio of early-stage research and manufacturing support solutions.READ MORE
-
Charles River Laboratories to Acquire HemaCare CorporationAcquisition expands CRL's scientific capabilities in the high-growth cell therapy market and establishes a comprehensive cell therapy solution from discovery through commercialization.READ MORE
-
HemaCare Expands Its Product Portfolio with GMPrimeTM Bone Marrow AspirateAdvancing cell and gene therapies with the highest quality GMP-compliant bone marrow starting materialREAD MORE
-
HemaCare and Charles River Laboratories Partner to Provide Human-Derived Biological Material to ChinaHemaCare and Charles River Laboratories partner to provide human-derived biological material to ChinaREAD MORE
Interested
Sign up for our newsletter for updates on events, news, and blog posts